- Home
- IPSC vs AIRG Comparison
IPSC vs AIRG Comparison
Compare IPSC & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- AIRG
- Stock Information
- Founded
- IPSC 2019
- AIRG 1995
- Country
- IPSC United States
- AIRG United States
- Employees
- IPSC N/A
- AIRG N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- AIRG Radio And Television Broadcasting And Communications Equipment
- Sector
- IPSC Health Care
- AIRG Technology
- Exchange
- IPSC Nasdaq
- AIRG Nasdaq
- Market Cap
- IPSC 47.4M
- AIRG 48.7M
- IPO Year
- IPSC 2021
- AIRG 2016
- Fundamental
- Price
- IPSC $0.59
- AIRG $4.30
- Analyst Decision
- IPSC Strong Buy
- AIRG Strong Buy
- Analyst Count
- IPSC 5
- AIRG 2
- Target Price
- IPSC $3.33
- AIRG $9.25
- AVG Volume (30 Days)
- IPSC 1.0M
- AIRG 15.6K
- Earning Date
- IPSC 08-07-2025
- AIRG 08-06-2025
- Dividend Yield
- IPSC N/A
- AIRG N/A
- EPS Growth
- IPSC N/A
- AIRG N/A
- EPS
- IPSC N/A
- AIRG N/A
- Revenue
- IPSC $114,898,000.00
- AIRG $58,381,000.00
- Revenue This Year
- IPSC $1,590.09
- AIRG N/A
- Revenue Next Year
- IPSC N/A
- AIRG $23.54
- P/E Ratio
- IPSC N/A
- AIRG N/A
- Revenue Growth
- IPSC 8286.72
- AIRG 8.46
- 52 Week Low
- IPSC $0.34
- AIRG $3.17
- 52 Week High
- IPSC $3.29
- AIRG $10.34
- Technical
- Relative Strength Index (RSI)
- IPSC 55.59
- AIRG 54.18
- Support Level
- IPSC $0.59
- AIRG $4.17
- Resistance Level
- IPSC $0.57
- AIRG $4.46
- Average True Range (ATR)
- IPSC 0.04
- AIRG 0.17
- MACD
- IPSC 0.00
- AIRG 0.00
- Stochastic Oscillator
- IPSC 66.59
- AIRG 55.90
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.